Table 2.
Hoehn and Yahr staging of Parkinson’s disease at baseline and following subcutaneous infusion of apomorphine.
| HY stage* | Baseline n (%) |
Month 6 n (%) |
pa | Month 12 n (%) |
pb |
|---|---|---|---|---|---|
| 2.0 | – | – | < 0.001 | 19 (37.3) | 0.013 |
| 2.5 | 2 (3.9) | 3 (5.9) | 32 (62.7) | ||
| 3.0 | 34 (66.7) | 25 (49.0) | – | ||
| 3.5 | 13 (25.5) | 21 (41.2) | – | ||
| 4 | 2 (3.9) | 2 (3.9) | – |
aChi-square test for baseline vs month 6 scores; bChi-square test for baseline vs month 12 scores; *Hoehn and Yahr stage of Parkinson’s disease. p < 0.05 was considered significant.